TENAX THERAPEUTICS, INC. Marketable Securities, Gain (Loss)
TENAX THERAPEUTICS, INC. (TENX) reported Marketable Securities, Gain (Loss) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLoss · last filed 2023-03-31
- TENAX THERAPEUTICS, INC. marketable securities, gain (loss) for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. marketable securities, gain (loss) for the quarter ending 2022-09-30 was $0.00.
- TENAX THERAPEUTICS, INC. marketable securities, gain (loss) for the quarter ending 2022-06-30 was $0.00.
- TENAX THERAPEUTICS, INC. marketable securities, gain (loss) for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. marketable securities, gain (loss) for fiscal 2022 was $0.00.
- TENAX THERAPEUTICS, INC. marketable securities, gain (loss) for fiscal 2021 was -$70.00, a 113.26% decline from fiscal 2020.
- TENAX THERAPEUTICS, INC. marketable securities, gain (loss) for fiscal 2020 was $528.00, a 810.34% increase from fiscal 2019.
- TENAX THERAPEUTICS, INC. marketable securities, gain (loss) for fiscal 2019 was $58.00.
| Period end | Marketable Securities, Gain (Loss) 3 month | Marketable Securities, Gain (Loss) 6 month | Marketable Securities, Gain (Loss) 8 month | Marketable Securities, Gain (Loss) 9 month | Marketable Securities, Gain (Loss) 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | $2.00 derived: sum of 4 quarters · filed 2023-03-31 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $2.00 derived: sum of 3 quarters · filed 2023-03-31 | -$274.00 derived: sum of 4 quarters · filed 2023-03-31 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | $2.00 derived: sum of 2 quarters · filed 2023-03-31 | -$274.00 derived: sum of 3 quarters · filed 2023-03-31 | -$402.00 derived: sum of 4 quarters · filed 2023-03-31 | |
| 2021-12-31 | $2.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$274.00 derived: sum of 2 quarters · filed 2023-03-31 | -$402.00 derived: sum of 3 quarters · filed 2023-03-31 | -$70.00 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$276.00 10-Q · filed 2022-11-10 | -$404.00 derived: sum of 2 quarters · filed 2022-11-10 | -$72.00 10-Q · filed 2022-11-10 | $901.00 derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$128.00 10-Q · filed 2022-08-11 | $204.00 10-Q · filed 2022-08-11 | $1.18K derived: sum of 3 quarters · filed 2022-08-11 | $2.35K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $332.00 10-Q · filed 2022-05-16 | $1.30K derived: sum of 2 quarters · filed 2022-05-16 | $2.48K derived: sum of 3 quarters · filed 2022-05-16 | -$762.00 derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $973.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $2.14K derived: sum of 2 quarters · filed 2022-03-29 | -$1.09K derived: sum of 3 quarters · filed 2022-03-29 | $528.00 10-K · filed 2022-03-29 | |
| 2020-09-30 | $1.17K 10-Q · filed 2021-11-15 | -$2.07K derived: sum of 2 quarters · filed 2021-11-15 | -$445.00 10-Q · filed 2021-11-15 | $416.00 derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | -$3.24K 10-Q · filed 2021-08-16 | -$1.62K 10-Q · filed 2021-08-16 | -$755.00 derived: sum of 3 quarters · filed 2021-08-16 | $205.00 derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $1.62K 10-Q · filed 2021-05-17 | $2.48K derived: sum of 2 quarters · filed 2021-05-17 | $3.44K derived: sum of 3 quarters · filed 2021-05-17 | $2.97K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $861.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-16 | $1.82K derived: sum of 2 quarters · filed 2021-04-16 | $1.35K derived: sum of 3 quarters · filed 2021-04-16 | $58.00 10-K/A · filed 2021-04-16 | |
| 2019-09-30 | $960.00 10-Q · filed 2020-11-16 | $486.00 derived: sum of 2 quarters · filed 2020-11-16 | -$803.00 10-Q · filed 2020-11-16 | -$11.30K derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | -$474.00 10-Q · filed 2020-08-14 | -$1.76K 10-Q · filed 2020-08-14 | -$12.26K derived: sum of 3 quarters · filed 2020-08-14 | -$18.77K derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | -$1.29K 10-Q · filed 2020-05-15 | -$11.79K derived: sum of 2 quarters · filed 2020-05-15 | -$18.30K derived: sum of 3 quarters · filed 2020-05-15 | -$28.86K derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | -$10.50K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$17.01K derived: sum of 2 quarters · filed 2020-03-30 | -$27.57K derived: sum of 3 quarters · filed 2020-03-30 | -$16.71K 10-K · filed 2020-03-30 | |
| 2018-09-30 | -$6.51K 10-Q · filed 2019-11-14 | -$17.07K derived: sum of 2 quarters · filed 2019-11-14 | -$6.21K 10-Q · filed 2019-11-14 | $4.23K derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | -$10.56K 10-Q · filed 2019-08-14 | $302.00 10-Q · filed 2019-08-14 | $10.74K derived: sum of 3 quarters · filed 2019-08-14 | $6.98K derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $10.86K 10-Q · filed 2019-05-15 | $21.30K derived: sum of 2 quarters · filed 2019-05-15 | $17.53K derived: sum of 3 quarters · filed 2019-05-15 | $14.87K derived: sum of 4 quarters · filed 2019-05-15 | |
| 2017-12-31 | $10.44K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $6.68K derived: sum of 2 quarters · filed 2019-04-01 | $4.02K derived: sum of 3 quarters · filed 2019-04-01 | -$2.52K 10-K · filed 2019-04-01 | |
| 2017-09-30 | -$3.77K 10-Q · filed 2018-11-14 | -$6.43K derived: sum of 2 quarters · filed 2018-11-14 | -$12.97K 10-Q · filed 2018-11-14 | $55.29K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | -$2.66K 10-Q · filed 2018-08-14 | -$9.20K 10-Q · filed 2018-08-14 | $59.06K derived: sum of 3 quarters · filed 2018-08-14 | $98.38K derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | -$6.54K 10-Q · filed 2018-05-15 | $61.72K derived: sum of 2 quarters · filed 2018-05-15 | $101.04K derived: sum of 3 quarters · filed 2018-05-15 | $22.97K derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $68.26K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $107.58K derived: sum of 2 quarters · filed 2018-04-02 | $29.51K derived: sum of 3 quarters · filed 2018-04-02 | -$110.72K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $39.32K 10-Q · filed 2017-11-09 | -$38.75K derived: sum of 2 quarters · filed 2017-11-09 | -$178.99K 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | -$78.07K 10-Q · filed 2017-08-09 | -$218.31K 10-Q · filed 2017-08-09 | |||
| 2016-03-31 | -$140.24K 10-Q · filed 2017-05-10 | ||||
| 2015-12-31 | $156.16K 10-K · filed 2017-03-16 | ||||
| 2015-10-31 | -$21.28K 10-Q · filed 2015-12-10 | $44.59K 10-Q · filed 2015-12-10 | |||
| 2015-09-30 | -$12.65K 10-Q · filed 2016-11-09 | -$122.61K 10-Q · filed 2016-11-09 | |||
| 2015-07-31 | $65.87K 10-Q · filed 2015-09-09 | ||||
| 2015-06-30 | $67.98K 10-Q · filed 2016-08-09 | -$109.96K 10-Q · filed 2016-08-09 | |||
| 2015-04-30 | $26.71K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$26.72K 10-K · filed 2017-03-16 | |||
| 2015-03-31 | -$177.94K 10-Q · filed 2016-05-10 | ||||
| 2015-01-31 | -$95.74K 10-Q · filed 2015-03-17 | -$118.99K derived: sum of 2 quarters · filed 2015-12-10 | -$53.43K 10-Q · filed 2015-03-17 | -$53.43K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2014-10-31 | -$23.25K 10-Q · filed 2015-12-10 | $42.31K 10-Q · filed 2015-12-10 | $42.31K derived: sum of 3 quarters · filed 2017-03-16 | $42.31K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2014-07-31 | $65.56K 10-Q · filed 2015-09-09 | $65.56K derived: sum of 2 quarters · filed 2017-03-16 | $65.56K derived: sum of 3 quarters · filed 2017-03-16 | $65.56K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2014-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | $0.00 10-K · filed 2017-03-16 | |
| 2014-01-31 | $0.00 10-Q · filed 2015-03-17 | $0.00 derived: sum of 2 quarters · filed 2015-03-17 | $0.00 10-Q · filed 2015-03-17 | ||
| 2013-10-31 | $0.00 10-Q · filed 2014-12-15 | $0.00 10-Q · filed 2014-12-15 | |||
| 2013-07-31 | $0.00 10-Q · filed 2014-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |